Are Hallucinogen Look-Alikes Illegal? DEA Delay Creates Limbo

Welcome to this week’s look at the cannabis and psychedelics industries. It’s been clear for a while that psychedelics companies face big challenges in the race to identify and patent substances that resemble classic drugs like psilocybin and LSD. But the regulatory twists this summer have just upped the ante.

The battle over obscure molecules that alter perception is heating up.